Introduces sulfonamide drugs and analytical context
p. 3
Presents and discusses analysis results
Specp. 4
Covers method sensitivity and related performance data
p. 5
Summarizes findings and method suitability
p. 2table, 23 rows
p. 4table, 19 rows
p. 5table, 19 rows
Table 2. Target analytes MRM conditions.
No.
Analyte
Precursor Ion (m/z)
Fragmentor (V)
Quant Product Ion (m/z)
CE (V)
Qual Product Ion (m/z)
CE (V)
1
Sulfacetamide
215.2
65
156
7
108
20
2
Sulfadiazine
251.3
100
156
16
92
32
3
Sulfathiazole
256
100
156.1
14
65.2
56
4
Sulfapyridine
250.3
110
91.9
32
156
16
5
Sulfamerazine
265.3
110
92
32
65.2
58
6
Trimethoprim
291.3
120
230.1
26
261
28
7
Sulfamethoxypyridazine
281.3
100
156
16
92.2
32
8
Sulfamoxole
271.3
90
92.1
28
65.1
56
9
Sulfadimidine
279.3
100
65.2
64
92.1
32
10
Sulfameter
281.3
110
156
16
92.2
34
11
Sulfachloropyridazine
285
100
156
14
92
36
12
Sulfamethoxazole
254.3
100
65.2
54
156
16
13
Sulfamonomethoxine
281.3
70
156
18
92.2
34
14
Sulfisoxazole
268.3
100
155.9
12
92.1
30
15
Sulfadoxine
311.4
130
156
18
92
34
16
Sulfabenzamide
277.2
80
156
12
108
28
17
Sulfaphenazole
315.4
130
65
78
92
43
18
Sulfadimethoxine
311.4
130
156
22
92
38
19
Sulfaquinoxaline
301.4
110
156.1
16
92.1
36
IS 1
13C6-Sulfadiazine
256
110
162
17
–
–
IS 2
13C3-Trimethoprim
294
120
230
38
–
–
IS 3
13C6-Sulfadimethoxine
317
130
162
21
–
–
IS 4
13C6-Sulfamoxole
277
90
162
28
–
–
Table 3. The 19 targeted SA drugs quantitation results.
Target
Retention Time (min)
Calibration Curve Linearity (R2)
LOD (ng/L)
LOQ (ng/L)
Sulfacetamide
2.84
0.999
0.29
1.16
Sulfadiazine
3.99
0.999
0.77
3.08
Sulfathiazole
4.69
0.999
1.09
4.36
Sulfapyridine
5.01
0.999
0.83
3.32
Sulfamerazine
5.47
0.999
1.35
5.4
Trimethoprim
6.28
0.999
1.23
4.92
Sulfamethoxypyridazine
6.44
0.999
1.01
4.04
Sulfamoxole
6.69
0.999
0.28
1.12
Sulfadimidine
6.96
0.999
1.24
4.96
Sulfameter
7.24
0.999
1.35
5.4
Sulfachloropyridazine
7.48
0.999
0.86
3.44
Sulfamethoxazole
7.71
0.999
0.98
3.92
Sulfamonomethoxine
8.08
0.999
0.31
1.24
Sulfisoxazole
8.56
0.996
1.51
6.04
Sulfadoxine
8.62
0.999
1.24
4.96
Sulfabenzamide
9.11
0.999
1.88
7.52
Sulfaphenazole
10.21
0.999
0.83
3.32
Sulfadimethoxine
11.19
0.999
0.93
3.72
Sulfaquinoxaline
11.88
0.999
1.26
5.04
Table 4. Spiking recovery and precision of targets in ground surface water at a level of 100 ng/L (n = 3).
No.
Compound
Average Recovery (%)
RSD (%)
1
Sulfacetamide
95.0
3.6
2
Sulfadiazine
94.4
2.1
3
Sulfathiazole
87.4
0.2
4
Sulfapyridine
85.3
3.4
5
Sulfamerazine
91.8
1.2
6
Trimethoprim
102
0.9
7
Sulfamethoxypyridazine
89.8
1.2
8
Sulfamoxole
88.5
2.0
9
Sulfadimidine
84.0
5.4
10
Sulfameter
94.6
3.11
11
Sulfachloropyridazine
88.6
4.9
12
Sulfamethoxazole
99.5
2.6
13
Sulfamonomethoxine
94.3
5.3
14
Sulfisoxazole
87.5
4.5
15
Sulfadoxine
77.9
6.8
16
Sulfabenzamide
86.8
2.4
17
Sulfaphenazole
78.4
7.0
18
Sulfadimethoxine
78.6
8.2
19
Sulfaquinoxaline
73.4
8.8
Engineering Facts
14 facts · every claim linked to a page
Selection
The HLB sorbent retains a broad range of compounds from polar to nonpolar and acidic to basic, so it is suitable for multi-class environmental screening.
Confirms method scope and sorbent suitability when selecting an SPE chemistry for mixed-analyte water methods.
Source
“This SPE sorbent provides good retention for a broad range of compounds from polar, to intermediate polar, to nonpolar compounds, and from acidic, to neutral, to basic compounds.”
Selection
The specific cartridge part number and format used are 6 mL, 500 mg Bond Elut HLB (p/n 5610-2147), which must be ordered to reproduce the method.
Ensures correct consumable selection and avoids method deviation from a different bed mass or format.
The SPE workflow requires a vacuum manifold with a collection rack for 10 × 75 mm test tubes (p/n 12234003).
Defines the manifold and collection hardware needed to set up the extraction bench correctly.
Source
“Agilent Vac Elut SPS 24 manifold with collection rack for 10 × 75 mm test tubes (part number 12234003)”
Operation
Adding NaEDTA raises sample pH to about 9 and degrades retention of sulfacetamide and sulfadiazine, so pH must be controlled.
Warns operators that EDTA addition alone is insufficient and pH adjustment is mandatory for reliable recovery.
Source
“the addition of NaEDTA to the water sample turned the water slightly basic, with a pH ~9, leading to unacceptable results and compromising sulfacetamide and sulfadiazine retention on the HLB sorbent.”
Operation
The sample must be adjusted to pH 4 to 7 with diluted HCl before loading to achieve best retention of the sulfonamides.
Specifies the critical pH window that governs analyte retention on the HLB cartridge.
Source
“Use diluted HCl to adjust the water to pH 4 to 7, then add 20 ng of IS 4.”
Operation
Cartridges are preconditioned with 6 mL MeOH and equilibrated with 6 mL water before sample loading.
Defines the conditioning sequence required to activate the sorbent and avoid poor or variable recovery.
Source
“Precondition the HLB cartridges with 6 mL of MeOH, and equilibrate with 6 mL of water.”
Operation
Sample loading should be performed at approximately 5 mL/min under vacuum to control residence time on the sorbent.
Gives the flow rate needed to keep loading reproducible and prevent breakthrough.
Source
“Transfer the prepared water sample gradually into the SPE cartridge, and apply vacuum for elution at ~5 mL/min.”
Operation
Elution uses 8 mL of MeOH (4 mL × 2) because 3 mL was insufficient for sulfamoxole and sulfabenzamide and 6 mL was marginal.
Specifies the elution volume and sequence needed to fully recover all 19 targets, including the more retentive ones.
Source
“Elute the HLB cartridges with MeOH, 4 mL × 2, and collect the eluent.”
Operation
The cartridge must be dried completely under high vacuum after the water wash before elution.
Residual water on the sorbent can dilute the eluate and reduce recovery; complete drying is a required step.
Source
“Wash the cartridge with 6 mL of water, and apply high vacuum at the end to dry the cartridge completely.”
Operation
The eluate is dried under nitrogen at 40 °C and reconstituted in 1 mL of 1:1 MeOH:water containing ISTDs 1–3.
Defines the concentration step and final solvent composition that affect injection and quantitation.
Source
“Dry the eluent with N2 flow at 40 °C, then reconstitute with 1 mL of 1:1 MeOH:water spiked with IS 1 to 3.”
Operation
The reconstituted sample must be filtered through a 0.2 µm nylon filter before LC/MS/MS injection.
Prevents particulates from reaching the column and injector, protecting the LC/MS system.
Source
“Filter the reconstituted sample with a 0.2 µm nylon filter. Samples are now ready for LC/MS/MS analysis.”
Performance
The method achieves LODs of 0.3 to 1.9 ng/L and LOQs of 1.2 to 7.6 ng/L, confirming suitability for trace-level water analysis.
Provides the sensitivity baseline engineers need to judge whether the method meets a given regulatory limit.
Source
“The LODs for all 19 SA drugs were within 0.3 to 1.9 ng/L, and limits of quantitation (LOQ) ranged between 1.2 to 7.6 ng/L.”
Performance
Recovery in spiked blank water is 74.3 to 118% for most targets, with sulfisoxazole below 65% at 4 and 10 ng/L.
Flags a known low-recovery analyte at trace levels so expectations and QC limits can be set realistically.
Source
“the recovery of 74.3 to 118% was achieved for most targets at four spiking levels, except the slight low recoveries (< 65%) of sulfisoxazole at the levels of 4 and 10 ng/L.”
Performance
In real ground surface water spiked at 100 ng/L, recovery is 73.4 to 102% with RSD 0.2 to 8.8%, confirming matrix applicability.
Demonstrates the method works in a real matrix, supporting its adoption for environmental monitoring.
Source
“The recovery of all of the targets ranged from 73.4 to 102%, with RSDs between 0.2 and 8.8%.”